
CIRS Group has systematically compiled and in-depth analyzed the August 2026 new cosmetic ingredient filing information published by the National Medical Products Administration (NMPA).

CIRS Group has systematically compiled and in-depth analyzed the August 2026 new cosmetic ingredient filing information published by the National Medical Products Administration (NMPA).

UK SAG-CS published seven final safety opinions on cosmetic ingredients, CIRS Group has compiled the conclusions and provided a regulatory interpretation for each ingredient.

On August 19, China's IECIC undergoes fifth dynamic adjustment. This article provides a detailed review of these five adjustments.

In July 2026, 18 new cosmetic ingredients were filed with China's NMPA, marking a 64% year-on-year increase and bringing the year-to-date total to 134. Domestic Chinese entities filed 15 of these ingredients—led by Shanghai, Zhejiang, and Guangdong—while overseas companies in Malaysia and the United States filed the remaining three.

Colorado Governor signed HB26-1135 which prohibits in-state sale and distribution of covered hair products with intentionally added carcinogens or reproductive toxicants effective July 1, 2027.

US FDA marks two major cosmetic rules (banning formaldehyde releasers in hair straighteners and mandating fragrance allergen labeling) for NPRM issuance in 2026.

EU plans to amend the EU Cosmetics Regulation, involving Annex II, III and V.

This article summarizes the core points based on the Technical General Principles for the Data of Registration and Filing of NCI.

CIRS Group has systematically compiled and in-depth analyzed the June 2026 new cosmetic ingredient filing information published by NMPA.

As of late June 2026, a cumulative total of 109 new cosmetic ingredients have completed filing in China, with six newly added in the past weeks as the pace of filing continues to accelerate.